Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Pharmacogenet Genomics ; 22(4): 305-9, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22336957

ABSTRACT

A novel NAT2 tagSNP (rs1495741) and a 2-SNP genotype (rs1041983 and rs1801280) have been recently shown to accurately predict the NAT2 acetylator phenotypes in populations of exclusive or predominant European/White ancestry. We confirmed the accuracy of the tagSNP approach in White Brazilians, but not in Brown or Black Brazilians, sub-Saharan Mozambicans, and Guarani Amerindians. The combined rs1041983 and rs1801280 genotypes provided considerably better prediction of the NAT2 phenotype in Guarani, but no consistent improvement in Brown or Black Brazilians and Mozambicans. Best predictions of the NAT2 phenotype in Mozambicans using NAT2 SNP pairs were obtained with rs1801280 and rs1799930, but the accuracy of the estimates remained inadequate for clinical use or for investigations in this sub-Saharan group or in Brazilians with considerable African ancestry. In conclusion, the rs1495741 tagSNP cannot be applied to predict the NAT2 acetylation phenotype in Guarani and African-derived populations, whereas 2-SNP genotypes may accurately predict NAT2 phenotypes in Guarani, but not in Africans.


Subject(s)
Acetylation , Arylamine N-Acetyltransferase/genetics , Black People/genetics , Polymorphism, Single Nucleotide/genetics , White People/genetics , Africa South of the Sahara , Arylamine N-Acetyltransferase/metabolism , Brazil , Genetics, Population , Genotype , HapMap Project , Humans , Phenotype , Predictive Value of Tests
SELECTION OF CITATIONS
SEARCH DETAIL